Pharmaceutical Raw Material Manufacturing in China - IBISWorld Industry Market Research

Pharmaceutical Raw Material Manufacturing in China

Pharmaceutical Raw Material Manufacturing in China - IBISWorld Industry Market Research
Pharmaceutical Raw Material Manufacturing in China
Published Dec 15, 2014
39 pages — Published Dec 15, 2014
Price US$ 660.00  |  Buy this Report Now

About This Report

  
Abstract:

China is one of the largest producers of pharmaceutical raw materials (PRMs), largely due to its low production cost advantage and large population. China accounts for roughly 90.0% of global vitamin C output, 70.0% of citric acid output and 90.0% of penicillin output.

Rising health concerns among Chinese people and strong global demand led to rapid industry growth in the past five years. Total revenue for the Pharmaceutical Raw Material Manufacturing industry in China is expected to be $71.32 billion in 2014, up 11.6% from 2013. Over the five years, revenue has been increasing steadily at an average annual rate of 15.9%.

The Pharmaceutical Raw Material Manufacturing industry in China manufactures active pharmaceutical ingredients for further preparation of finished pharmaceutical products. Typical products in the industry include bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. This industry acts as a bridge between the upstream chemical industry and the downstream medical market.

The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.

  
Source:
Document ID
2710
Country
Report Type
Format:
PDF Adobe Acrobat
Buy Now

IBISWorld Industry Market Research—IBISWorld is a leading strategic business information provider that offers comprehensive information on more than 700 US industries covering 4,000 individual product segments. They also provide global industry and industry risk rating reports covering Australia, the United Kingdom and China. IBISWorld data offers detailed analysis on growth trends, the competitive environment and key issues. Reports average 30 to 40 pages and contain figures; market characteristics; product, market and service segmentation; industry conditions, current and historical performance analysis; risk scores; industry participants and market share; factors to success; and 5-year forecasts with forecast analysis.

About the Author


Cite this Report

  
MLA:
IBISWorld Industry Market Research. "Pharmaceutical Raw Material Manufacturing in China" Dec 15, 2014. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/IBISWorld-Industry-Market-Research/Pharmaceutical-Raw-Material-Manufacturing-in-China-2042-31>
  
APA:
IBISWorld Industry Market Research. (2014). Pharmaceutical Raw Material Manufacturing in China Dec 15, 2014. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/IBISWorld-Industry-Market-Research/Pharmaceutical-Raw-Material-Manufacturing-in-China-2042-31>
  
US$ 660.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.